Group 1: Company Overview and Business Strategy - The company aims to be the closest supply chain management service provider to customers, focusing on smart supply chain services and understanding the upstream and downstream of the industries served [2][4]. - The company has identified opportunities for growth due to national policies, technological advancements, and increasing health awareness among the population [2][3]. Group 2: Competitive Advantages - The company possesses excellent supply chain management consulting solutions and agile operational capabilities, helping clients achieve "just-in-time" production and "zero inventory" management [4][5]. - A combination of standardized and customized service models allows the company to meet diverse client needs across various industries [4][5]. - The company has a strong management team with extensive experience in supply chain management, particularly in the electronic information and medical device sectors [5][6]. Group 3: Financial Performance - In 2021, the company reported cash inflows related to operational activities amounting to 75.2 billion, primarily from service clients like Xiaomi [5][6]. - The company’s revenue from the medical device sector was 1,184.96 million, showing a year-on-year decrease of 34.76%, while the financing leasing business generated 9.30 million, down 25.73% [8][9]. - The service sector revenue grew by 23.7% to 292 million, driven by the ICT industry [8][9]. Group 4: Market Challenges and Future Outlook - The company has faced revenue declines due to factors such as US-China trade tensions and the COVID-19 pandemic, leading to a shift towards a light-asset and efficient operational model [6][7]. - The company plans to continue expanding into new fields and investing to enhance operational scale and efficiency [7][8]. - The company’s growth logic is based on the necessity of cost reduction and digital supply chain management support across various industries [6][7].

深圳市普路通供应链管理股份有限公司 2022 年第三季度报告 证券代码：002769 证券简称：普路通 公告编号：2022-036 深圳市普路通供应链管理股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 477,574,161.22 | -13.59% | 1,212,257,085.57 | -38.76% | | 归属于上市公司股东 | -5,738,059.08 | - | 4,429,029.35 ...

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥734.68 million, a decrease of 48.51% compared to ¥1.43 billion in the same period last year[21]. - The net profit attributable to shareholders was approximately ¥10.17 million, down 69.83% from ¥33.70 million in the previous year[21]. - Basic earnings per share decreased by 66.67% to ¥0.03 from ¥0.09 in the previous year[21]. - Total revenue for the reporting period was ¥734,682,924.35, a decrease of 48.51% compared to ¥1,426,896,440.6 in the same period last year[40]. - The company reported a total comprehensive income of CNY 3,717,121.19 for the first half of 2022, compared to CNY 26,211,927.46 in the first half of 2021, indicating a decrease of 85.8%[133]. - The company reported a total comprehensive income of ¥483,361,604.70 for the current period, compared to ¥521,145,855.83 in the previous period, indicating a decrease of about 7.2%[140]. Cash Flow and Liquidity - The net cash flow from operating activities was approximately ¥462.75 million, a significant improvement from a negative cash flow of ¥485.76 million in the same period last year[21]. - The company reported a net increase in cash and cash equivalents of CNY 230,215,199.48, compared to a decrease of CNY 24,984,714.23 in the previous year[38]. - Cash and cash equivalents at the end of the reporting period were ¥2,474,834,889, representing 47.49% of total assets, an increase of 25.31% from ¥844,483,699[43]. - The total cash inflow from financing activities was CNY 2,163,959,270.06, an increase from CNY 1,891,672,849.00 in the first half of 2021[135]. - The total cash and cash equivalents at the end of the period amounted to ¥433,552,268.15, compared to ¥624,576,352.81 at the end of the previous period, representing a decrease of approximately 30.6%[137]. Operational Efficiency - The company is focusing on maintaining core business stability while gradually expanding into new business areas to enhance operational efficiency[34]. - The company plans to enhance its market expansion strategies and invest in new product development to drive future growth[143]. - The company has set a target to improve operational efficiency and reduce costs by 4.6% in the upcoming quarters[143]. - The company is focusing on technological advancements and innovation to maintain competitive advantage in the supply chain management sector[143]. Investments and Acquisitions - The company invested ¥16,000,000 during the reporting period, a significant increase of 4,900% compared to ¥320,000 in the same period last year[45]. - There are plans for strategic acquisitions to enhance service offerings, with a budget allocation of 500 million RMB for potential targets in the logistics sector[71]. - The company is investing in technology development, with a commitment of 100 million RMB towards R&D for advanced supply chain management systems[70]. Risks and Challenges - The company is facing operational risks as outlined in the management discussion and analysis section, which investors are advised to review[4]. - The company faces risks from domestic COVID-19 outbreaks and macroeconomic conditions, which may lead to reduced customer demand and business volume[51]. - The company is focusing on maintaining customer service quality and optimizing internal management to mitigate risks associated with economic fluctuations[51]. Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for this reporting period[4]. - The company has a participation rate of 40.45% in the annual shareholders' meeting held on May 24, 2022[57]. - The largest shareholder, Chen Shuzhi, holds 17.18% of the shares, totaling 64,149,567 shares[104]. Legal Matters - The company is involved in a lawsuit with Guangzhoushi Junya Medical Device Co., with a disputed amount of 41.36 million yuan, which has been adjudicated but still has some execution amounts pending[75]. - Another lawsuit involves the subsidiary Qianhai Ruitai against Longling County People's Hospital, with a disputed amount of 21.28 million yuan, which has been adjudicated but still has some execution amounts pending[76]. - The company is also in a contract dispute with Gansu Chuangjishi Trading Co., with a disputed amount of 15.05 million yuan, which has been filed but has no significant impact[76]. Financial Position - Total assets increased by 36.89% to approximately ¥5.21 billion compared to ¥3.81 billion at the end of the previous year[21]. - Total liabilities increased to ¥3,733,339,132.78 from ¥2,331,965,204.67, indicating a rise of around 60.1%[121]. - The company's total equity increased slightly to ¥1,477,764,753.84 from ¥1,474,699,591.94, reflecting a marginal growth of about 0.2%[121]. Corporate Governance - There were no changes in the board of directors, supervisors, or senior management during the reporting period[58]. - The company has not implemented any stock incentive plans or employee stock ownership plans during the reporting period[60]. - The company ensures the independence of its financial department and accounting system[67]. Compliance and Reporting - The half-year financial report has not been audited, but the company assures transparency and adherence to accounting standards[73]. - The company adheres to the accounting standards set by the Ministry of Finance, ensuring accurate financial reporting[155]. - The company has not reported any significant changes in its accounting policies or estimates during the reporting period[157].

Financial Performance - The company's operating revenue for 2021 was ¥2,572,254,463.66, representing a decrease of 20.98% compared to ¥3,255,111,387.16 in 2020[18]. - The net profit attributable to shareholders for 2021 was ¥36,704,464.31, down 45.78% from ¥67,692,388.04 in 2020[18]. - The net profit after deducting non-recurring gains and losses was ¥14,239,137.39, a decline of 72.17% from ¥51,172,265.12 in 2020[18]. - The total assets at the end of 2021 were 3,806,664,796.61 CNY, a decrease of 37.60% compared to the end of 2020[24]. - The basic and diluted earnings per share for 2021 were both 0.10 CNY, down 44.44% from 0.18 CNY in 2020[24]. - The net cash flow from operating activities was -404,901,243.21 CNY, a decline of 3,799.35% compared to the previous year[24]. - The weighted average return on equity was 2.51% for 2021, down from 4.76% in 2020[24]. - The company reported a total of 22,465,326.92 CNY in non-recurring gains and losses for 2021, compared to 16,520,122.92 CNY in 2020[25]. - The operating profit for the year was CNY 49,016,000, down 44.68% year-on-year, while the net profit attributable to shareholders was CNY 36,704,500, a decline of 45.78%[43]. - The transaction business accounted for 84.92% of total revenue, totaling CNY 2,184,481,363.38, which represents a 24.23% decrease from the previous year[45]. - Service business revenue increased by 23.66% to CNY 292,377,525.01, making up 11.37% of total revenue[45]. Business Operations - The company has not changed its main business since its listing, maintaining its focus on supply chain management[17]. - The company has expanded its business segments to include ICT supply chain management, medical B2B, financial leasing, cross-border e-commerce, and municipal infrastructure[30]. - The company aims to enhance supply chain value through professional and customized management services, responding to the increasing demand for efficient collaboration and rapid response capabilities[30]. - The company provides integrated supply chain solutions, including design, optimization, inventory management, and logistics support, to enhance supply chain efficiency and innovation for clients[33]. - The company is positioned as a leading player in the domestic supply chain management industry, supported by government policies promoting supply chain innovation and application[30]. - The company has established strategic partnerships with international medical device manufacturers, facilitating efficient procurement for domestic hospitals and institutions, thus reducing costs and procurement cycles[34]. - The financing leasing business is strategically integrated with existing operations, helping medical clients manage capital allocation effectively and enhancing the company's profitability and competitive edge[34]. - The cross-border e-commerce business offers comprehensive supply chain management solutions, including customs clearance and overseas procurement, leveraging the company's expertise in import and export[35]. - The company is expanding its supply chain management services to municipal infrastructure and construction sectors, providing tailored solutions to enhance clients' competitiveness[36]. Risk Management - The company emphasizes the importance of risk awareness for investors regarding future operational plans[4]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the audit report[24]. - Risks include potential declines in business volume due to the ongoing COVID-19 pandemic and macroeconomic changes, as well as reliance on the ICT industry[85]. - The company faces foreign exchange risk due to significant overseas procurement, which it mitigates through fixed-income foreign exchange products[85]. - The company emphasizes the importance of managing accounts receivable risks by focusing on high-quality clients and enhancing credit evaluation processes[87]. Governance and Compliance - The company adheres strictly to legal regulations and its information disclosure management system, ensuring timely and accurate information dissemination to all investors[98]. - The company operates independently from its controlling shareholders in terms of business, personnel, assets, institutions, and finances, ensuring complete operational autonomy[99]. - The company has established an independent financial department with its own accounting system and tax obligations, without providing guarantees for related parties[104]. - The company has a complete supply chain management business system and sales system, independently operating in the market without interference from controlling shareholders[100]. - The company has a well-established organizational structure, allowing independent operation of its various departments[103]. - The company’s governance practices align with the regulations set forth by the China Securities Regulatory Commission, with no significant discrepancies noted[98]. Employee and Management - The total number of employees at the end of the reporting period was 358, with 206 in the parent company and 152 in major subsidiaries[134]. - The company has a dedicated human resources department and management team, ensuring that senior management does not hold positions in controlling entities[101]. - The company implements a compensation policy of "fixed salary + variable salary + year-end bonus," ensuring compliance with national labor regulations and providing social security benefits[135][136]. - The company has established a performance evaluation system linking the remuneration of management to company performance and individual performance[120]. - The management team has extensive experience in finance and supply chain management, contributing to strategic decision-making[113]. Future Outlook - The company aims to leverage technology to improve service delivery and customer satisfaction in the supply chain sector[112]. - Future growth strategies include market expansion and potential mergers and acquisitions to enhance competitive positioning[112]. - The company has provided a revenue guidance of 1.5 billion RMB for the next fiscal year, which reflects an expected growth of 25%[117]. - New product launches are expected to contribute an additional 300 million RMB in revenue, with a focus on enhancing supply chain solutions[117]. - The company is investing 100 million RMB in R&D for new technologies aimed at improving operational efficiency[117]. - Market expansion plans include entering two new provinces, which are projected to increase market share by 10%[117]. Shareholder Information - The company proposed a cash dividend of 0.20 CNY per 10 shares, totaling 7,466,361.08 CNY, which represents 100% of the profit distribution[139]. - The largest shareholder, Mr. Chen Shuzhi, transferred voting rights for 71,559,567 shares (19.18% of total shares) to Green Gold Investment[189]. - Following the expiration of the voting rights entrustment, Mr. Chen Shuzhi regained control with 64,149,567 shares (17.18% of total shares)[190]. - The company has a significant ownership structure, with major shareholders holding 10.66% of the shares each[111]. - The total number of shares is 373,318,000, with 29.35% being restricted shares and 70.65% being unrestricted shares[193]. Legal Matters - The company is involved in ongoing litigation with Guangzhou Junya Medical Equipment Co., with a disputed amount of 41.36 million yuan, which has been ruled but is still partially in execution[170]. - Another ongoing case involves a dispute with China Railway 10th Bureau Group, with a disputed amount of 41.09 million yuan, which has reached a settlement agreement but is still in execution[170]. - The company has no significant penalties or rectification issues during the reporting period[171].

Financial Performance - The company's revenue for Q1 2022 was ¥344,422,411.43, a decrease of 50.48% compared to ¥695,511,779.71 in the same period last year[3] - Net profit attributable to shareholders was ¥11,970,070.52, down 47.47% from ¥22,788,785.85 year-on-year[3] - Basic and diluted earnings per share both decreased by 50.00% to ¥0.03 from ¥0.06[3] - Total operating revenue for Q1 2022 was CNY 344,422,411.43, a decrease of 50.5% compared to CNY 695,511,779.71 in the same period last year[19] - Net profit for Q1 2022 was CNY 11,961,906.97, a decline of 47.5% compared to CNY 22,802,780.63 in Q1 2021[20] Cash Flow - The net cash flow from operating activities was ¥373,025,136.06, a significant improvement from a negative cash flow of ¥388,068,109.17 in the previous year[3] - The company reported a net cash flow from operating activities of CNY 373,025,136.06, recovering from a negative cash flow of CNY -388,068,109.17 in the previous year[22] - The net cash flow from investment activities was -4,022,210.61, indicating a significant outflow compared to the previous quarter's outflow of -64,863.51[24] - Cash inflow from financing activities totaled 824,743,121.04, a decrease from 1,113,888,042.17 in the previous quarter[24] - The net cash flow from financing activities was 38,669,569.06, down from 355,513,932.50 in the previous quarter[24] Assets and Liabilities - Total assets increased by 4.05% to ¥3,960,647,554.39 compared to ¥3,806,664,796.61 at the end of the previous year[3] - The company's total current assets amount to approximately CNY 3.68 billion, an increase from CNY 3.52 billion at the beginning of the year[16] - The total liabilities include approximately CNY 974.04 million in other payables[16] - The company’s total liabilities increased to CNY 2,473,684,947.53, compared to CNY 2,331,965,204.67 in the previous year[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 23,502[11] - The largest shareholder, Chen Shuzhi, holds 17.18% of the shares, totaling 64,149,567 shares[11] - The company has a total of 39,810,538 shares with voting rights available to the former major shareholder, Green Investment[14] Operating Costs and Expenses - The company’s operating costs decreased by 52.08% to ¥293,020,737.37, reflecting the reduction in sales[8] - Total operating costs for Q1 2022 were CNY 348,916,281.76, down 47.1% from CNY 660,673,190.76 year-over-year[19] - The financial expenses increased by 92.42% to ¥6,588,566.70, primarily due to exchange rate fluctuations[8] - The company incurred research and development expenses of CNY 3,218,844.04, a decrease from CNY 3,572,778.43 in the same period last year[19] Fair Value and Foreign Exchange - The company recorded a fair value change gain of ¥13,821,036.88, attributed to foreign exchange risk management strategies[5] - The company reported a significant increase in fair value gains of CNY 13,821,036.88 compared to a loss of CNY -4,618,593.71 in the previous year[19] - The company experienced a negative impact of -420,295.68 from foreign exchange fluctuations on cash and cash equivalents[24] Other Information - The company has not disclosed any new product developments or market expansion strategies in the current report[13] - The company did not undergo an audit for the first quarter report[25] - The report was issued by the company's legal representative, Chen Shuzhi, on April 29, 2022[26]

Financial Performance - The company's revenue for Q3 2021 was ¥552,691,695.13, a decrease of 30.43% compared to the same period last year[3] - The net profit attributable to shareholders was a loss of ¥3,818,504.18, representing a decline of 151.16% year-over-year[3] - The net profit after deducting non-recurring gains and losses was a loss of ¥16,739,903.73, down 376.05% from the previous year[3] - Total operating revenue for Q3 2021 was CNY 1,979,588,135.75, a decrease of 12.5% compared to CNY 2,262,540,854.55 in the same period last year[19] - Net profit for Q3 2021 was CNY 30,120,160.35, representing a decline of 26.7% from CNY 41,075,638.81 in Q3 2020[20] - The company's basic earnings per share for Q3 2021 was -¥0.01, a decrease of 150.00% compared to the same period last year[3] - Earnings per share for Q3 2021 were CNY 0.08, down from CNY 0.11 in the previous year[21] - The company's total comprehensive income for Q3 2021 was CNY 30,468,799.05, down from CNY 44,138,674.88 in Q3 2020[21] Cash Flow and Liquidity - The cash flow from operating activities was negative at ¥261,141,708.54 for the year-to-date period[3] - The net cash flow from operating activities was CNY -261,141,708.54, a decline of CNY 111,707,600.99 compared to CNY -149,434,107.55 in the previous year[10] - Cash inflow from operating activities was CNY 2,835,632,831.88, a decrease from CNY 3,077,749,613.70 in the same quarter last year[22] - The company reported a total cash and cash equivalents balance of 641,129,322.93 CNY at the end of the quarter, a decrease from 761,497,145.72 CNY at the beginning of the quarter[24] - The cash outflow for operating activities related to taxes and other operational cash payments totaled 93,616,025.52 CNY and 59,287,624,542.48 CNY respectively[24] Assets and Liabilities - The total assets at the end of Q3 2021 were ¥3,913,008,985.58, a decrease of 35.85% from the end of the previous year[4] - Total assets decreased to CNY 3,913,008,985.58 from CNY 6,099,962,497.04 at the end of the previous year[16] - Total liabilities decreased to CNY 2,447,488,049.53 from CNY 4,650,686,652.97 year-over-year[18] - The total liabilities increased to 4,650,686,652.97 CNY from 4,672,996,595.96 CNY, reflecting a slight rise in financial obligations[28] - The company's total assets amounted to 6,099,962,497.04 CNY, showing a minor increase compared to 6,121,490,830.07 CNY at the beginning of the year[28] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 25,610[12] - The top shareholder, Chen Shuzhi, holds 17.18% of the shares, totaling 64,149,567 shares[12] Government Support - The company received government subsidies amounting to ¥16,814,826.42 during the reporting period[6] Other Financial Metrics - The weighted average return on equity was -0.25% for Q3 2021, down from 2.05% in the previous year[4] - The company reported a significant increase in other payables, rising to CNY 876,988,500.10 from CNY 398,980,353.95[18] - The company experienced a fair value loss of CNY 1,132,027.12 compared to a loss of CNY 40,476,721.50 in the previous year[20] - The company adjusted its financial statements due to the first-time implementation of new leasing standards, affecting the balance sheet items[25] - The company has not undergone an audit for the third-quarter report, indicating that the figures are unaudited[29]

Financial Performance - The company's operating revenue for the first half of 2021 was ¥1,426,896,440.62, a decrease of 2.81% compared to ¥1,468,104,996.55 in the same period last year[19]. - The net profit attributable to shareholders of the listed company was ¥33,703,339.95, showing a slight increase of 0.37% from ¥33,577,739.95 in the previous year[19]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥28,110,717.84, representing a significant increase of 15.43% compared to ¥24,352,537.91 in the same period last year[19]. - The net cash flow from operating activities was negative at ¥485,762,526.59, worsening from a negative cash flow of ¥336,162,442.33 in the previous year[19]. - Total assets at the end of the reporting period were ¥4,097,853,090.79, a decrease of 32.82% from ¥6,099,962,497.04 at the end of the previous year[19]. - The basic and diluted earnings per share remained unchanged at ¥0.09[19]. - The weighted average return on net assets was 2.30%, a slight decrease from 2.40% in the previous year[19]. - The company's operating costs decreased by 3.24% to ¥1,201,667,998.36 from ¥1,241,918,958.83 year-on-year[48]. - The service business revenue increased significantly by 77.61% to ¥142,581,676.66, driven by growth in customer business volume and new client development[52]. - The company reported a significant reduction in financial expenses by 82.70% to ¥2,218,329.15, primarily due to exchange rate fluctuations[49]. - The company reported a net profit margin of 12%, reflecting improved profitability compared to the previous year[184]. Cash Flow and Liquidity - The company's cash flow from operating activities showed a net outflow of ¥485,762,526.59, which is a deterioration compared to a net outflow of ¥336,162,442.33 in the previous year[49]. - Cash and cash equivalents decreased significantly from CNY 3.73 billion at the end of 2020 to CNY 1.47 billion, a reduction of about 60.5%[122]. - The ending balance of cash and cash equivalents was 736,512,431.49 CNY, down from 761,497,145.72 CNY at the beginning of the period[141]. - The company reported a net increase in cash and cash equivalents of -24,984,714.23 CNY, contrasting with a positive increase of 55,107,996.34 CNY in the previous period[141]. - Total cash inflow from operating activities was 35,005,048,172.77 CNY, while cash outflow was 35,490,810,699.36 CNY, resulting in a net cash flow deficit[140]. Assets and Liabilities - As of the end of the reporting period, cash and cash equivalents amounted to CNY 1,472,695,383, representing 35.94% of total assets, a decrease of 25.14% compared to the previous year[55]. - Accounts receivable stood at CNY 817,048,279.43, accounting for 19.94% of total assets, an increase of 6.51% from the previous year[55]. - Inventory increased to CNY 139,204,528.49, which is 3.40% of total assets, up by 1.57% year-on-year[55]. - Short-term borrowings decreased significantly to CNY 535,605,282.80, representing 13.07% of total assets, a reduction of 19.59% compared to the previous year[55]. - The total liabilities decreased to CNY 4,436,360,981.58 from CNY 5,944,808,913.00, indicating a reduction in financial obligations[129]. - The company's total assets decreased to CNY 5,731,364,074.31 from CNY 7,227,040,449.94, reflecting a contraction in the asset base[129]. Strategic Initiatives - The company maintains stable growth in the ICT sector and medical device supply chain management, focusing on key regions such as South China, Southwest, and Northwest[37]. - The financing leasing business is being cautiously operated due to tightening financial regulations and economic pressures, with a focus on risk control[38]. - The company offers integrated supply chain management solutions, aiming for "zero inventory" and "just-in-time" production for ICT clients[40]. - The company has established strategic partnerships with international medical device manufacturers to enhance its market presence[28]. - The company is actively expanding its cross-border e-commerce business, collaborating with key clients to strengthen customer loyalty[38]. - The company plans to implement digital transformation in supply chain management by introducing technologies such as OCR, RPA, BI, and AI[43]. - The company is focusing on new product development and technological advancements to drive future growth[147]. - The company plans to enhance its market expansion efforts, although specific figures were not disclosed in the report[147]. Shareholder and Governance - The company plans not to distribute cash dividends or issue bonus shares[5]. - The total number of ordinary shareholders at the end of the reporting period was 27,034[108]. - The largest shareholder, Chen Shuzhi, held 19.18% of the shares, totaling 71,599.56 million[108]. - The second-largest shareholder, Zhang Yun, held 6.93% of the shares, totaling 25,877.96 million[108]. - There were no stock incentive plans or employee stock ownership plans implemented during the reporting period[71]. - The company did not engage in any significant litigation or arbitration matters during the reporting period[84]. - The semi-annual financial report for 2021 was not audited[120]. Risk Management - The company has developed a risk control system to manage various operational and financial risks, ensuring effective classification and rating of clients[46]. - The company is committed to maintaining close communication with clients to mitigate risks associated with macroeconomic fluctuations[62]. - The company plans to enhance its cash management capabilities to mitigate foreign exchange risks associated with overseas procurement[64]. - The company has established criteria for determining significant increases in credit risk, including changes in the debtor's expected performance and repayment behavior[200]. Compliance and Reporting - The company follows the accounting standards set by the Ministry of Finance, ensuring that its financial reports reflect its financial position and operating results accurately[165]. - The financial statements were approved by the board of directors on August 27, 2021[160]. - The company has not identified any significant doubts regarding its ability to continue as a going concern for the next 12 months[163].

Financial Performance - The company's operating revenue for Q1 2021 was ¥695,511,779.71, representing a 16.98% increase compared to ¥594,572,074.60 in the same period last year[7]. - The net profit attributable to shareholders was ¥22,788,785.85, up 23.19% from ¥18,499,413.78 year-on-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥20,270,802.29, reflecting a 27.00% increase from ¥15,961,116.10 in the previous year[7]. - The basic earnings per share increased by 20.00% to ¥0.06 from ¥0.05 in the same period last year[7]. - The net profit for Q1 2021 reached CNY 22,802,780.63, compared to CNY 18,541,045.63 in the same period last year, reflecting a growth of approximately 22.3%[38]. - The total profit for the quarter was CNY 29,623,031.26, up from CNY 24,969,258.25, indicating an increase of about 18.5%[38]. - The basic and diluted earnings per share for Q1 2021 were both CNY 0.06, compared to CNY 0.05 in the previous year[39]. - The company reported a comprehensive income total of CNY 21,581,692.27 for Q1 2021, an increase from CNY 16,798,003.46 in the same quarter last year[39]. - The total comprehensive income attributable to the parent company's shareholders was CNY 21,567,697.49, up from CNY 16,756,371.61 in the previous year[39]. Assets and Liabilities - The total assets at the end of the reporting period were ¥5,473,958,204.50, a decrease of 10.26% from ¥6,099,962,497.04 at the end of the previous year[7]. - The company's total assets decreased to CNY 6,938,318,054.07 from CNY 7,227,040,449.94 at the end of 2020[33]. - The company's total assets decreased from ¥6,099,962,497.04 to ¥5,473,958,204.50, indicating a decline in overall asset value[29]. - The total liabilities decreased to CNY 5,648,590,341.98 from CNY 5,944,808,913.00, indicating a reduction in financial leverage[34]. - The company's short-term borrowings decreased from ¥1,992,166,805.48 to ¥1,594,076,724.79, reflecting a reduction in debt levels[29]. - Current liabilities totaled CNY 5,636,451,606.42, a decrease from CNY 5,944,808,913.00 in the previous period[34]. - The total liabilities increased slightly by CNY 13,232,922.47, reaching CNY 5,958,041,835.47[56]. Cash Flow - The company reported a net cash flow from operating activities of -¥388,068,109.17, an improvement from -¥635,635,539.39 in the same period last year[7]. - The company's net cash flow from operating activities improved by ¥247,567,430.22, from -¥635,635,539.39 to -¥388,068,109.17, attributed to reduced working capital investment[16]. - The net cash flow from operating activities was -388,068,109.17 CNY, compared to -635,635,539.39 CNY in the previous period, indicating an improvement of approximately 39%[46]. - Total cash inflow from operating activities reached 16,033,560,819.24 CNY, up from 14,080,847,161.90 CNY, representing an increase of about 13.9%[48]. - Cash outflow from operating activities totaled 16,520,524,441.74 CNY, compared to 14,676,813,912.72 CNY, reflecting a rise of approximately 12.5%[48]. - The net cash flow from financing activities was 355,513,932.50 CNY, down from 645,624,607.49 CNY, showing a decrease of about 44.9%[47]. - The cash inflow from financing activities was 1,113,888,042.17 CNY, down from 1,518,882,892.22 CNY, reflecting a decrease of approximately 26.6%[47]. - The company experienced a net decrease in cash and cash equivalents of -32,570,871.17 CNY, contrasting with an increase of 11,150,580.23 CNY in the previous period[47]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 26,039[11]. - The net assets attributable to shareholders increased by 1.49% to ¥1,470,711,609.80 from ¥1,449,143,912.31 at the end of the previous year[7]. - The company's retained earnings increased to CNY 760,190,732.73 from CNY 737,401,946.88, showing a positive trend in profit retention[31]. - The company's retained earnings were CNY 737,401,946.88, showing a minor increase from the previous period[54]. Operational Efficiency - The company's trading financial assets decreased by 70.33%, from ¥13,373,834.98 to ¥3,967,474.35, primarily due to the fair value measurement of unexpired foreign exchange products[15]. - Other current assets increased by 105.36%, from ¥24,275,531.54 to ¥49,851,208.48, mainly due to the increase in foreign exchange products[15]. - Interest income rose by 48.35%, from ¥9,710,694.05 to ¥14,405,593.20, driven by increased interest income from foreign exchange products[15]. - The company's investment income surged by 3117.68%, from ¥114,802.90 to ¥3,693,993.53, reflecting higher investment returns from foreign exchange products[15]. - Contract liabilities decreased by 43.63%, from ¥185,242,116.68 to ¥104,418,678.94, mainly due to a reduction in customer prepayments[15]. - The company reported a significant decrease in sales expenses by 39.73%, from ¥38,097,002.27 to ¥22,962,206.54, due to reduced market expansion costs[15]. Other Information - The first quarter report was not audited, which may affect the reliability of the financial data presented[58]. - The company has not indicated any new product launches or significant market expansion strategies in the current report[58].

Financial Performance - The company's operating revenue for 2020 was ¥3,255,111,387.16, a decrease of 50.02% compared to ¥6,512,430,900.39 in 2019[16] - The net profit attributable to shareholders for 2020 was ¥67,692,388.04, representing an increase of 7.55% from ¥62,942,762.72 in 2019[16] - Basic earnings per share for 2020 were ¥0.18, up 5.88% from ¥0.17 in 2019[17] - Total assets at the end of 2020 were ¥6,099,962,497.04, a decrease of 6.35% from ¥6,513,236,919.20 at the end of 2019[17] - The net assets attributable to shareholders increased by 4.87% to ¥1,449,143,912.31 at the end of 2020, compared to ¥1,381,853,954.18 at the end of 2019[17] - The company reported a net cash flow from operating activities of ¥51,172,265.12 for 2020, down 17.41% from ¥61,960,936.18 in 2019[16] - The weighted average return on equity for 2020 was 4.76%, slightly up from 4.63% in 2019[17] - The company's operating profit for the year was CNY 8,860.42 million, a slight decrease of 0.75% year-on-year[46] - The company achieved operating revenue of CNY 325,511.14 million in 2020, a year-on-year decrease of 50.02% due to changes in accounting policies[46] - The company realized a net profit attributable to shareholders of CNY 6,769.24 million, an increase of 7.55% year-on-year[46] Cash Dividends - The company plans to distribute a cash dividend of ¥0.36 per 10 shares, based on a total of 373,318,054 shares[4] - The company proposed a cash dividend of RMB 0.36 per 10 shares for the year 2020, totaling RMB 13,501,955.67, which is 19.95% of the net profit attributable to shareholders[111] - The cash dividend payout ratio for 2020 was 100% of the total profit distribution[111] - The cash dividend for 2019 was RMB 0.18 per 10 shares, totaling RMB 6,719,724.97, which was 10.68% of the net profit[110] - The cash dividend for 2018 was RMB 0.47 per 10 shares, totaling RMB 17,545,948.54, which was 17.18% of the net profit[110] Business Operations and Strategy - The company has not made any changes to its main business since its listing[15] - The company has established strategic partnerships in the medical device sector, enhancing its supply chain management capabilities[27] - The company is expanding its financing leasing business in the medical device sector to alleviate clients' financial pressures[28] - The cross-border e-commerce business is being optimized to provide comprehensive supply chain management solutions, including customs clearance and overseas procurement[29] - The company is developing a global delivery platform to support the "Belt and Road" initiative, integrating resources for comprehensive supply chain services[32] - The company has expanded its business segments to include traditional supply chain ICT, medical B2B, financing leasing, cross-border e-commerce, municipal infrastructure, and global delivery[35] - The company plans to introduce technologies such as OCR, RPA, BI, and AI for digital transformation in supply chain management[40] - The company has established strategic partnerships with multiple banks, ensuring sufficient credit lines to support rapid expansion and meet growing payment needs[42] Risk Management - The company has indicated potential risks in its future operations, which are detailed in the report[4] - The company has implemented a risk control system to manage various operational and financial risks associated with supply chain management[43] - The company faces risks from macroeconomic factors such as US-China trade tensions and the ongoing pandemic, which may affect customer demand and business volume[97] - The company is exposed to risks related to its reliance on the ICT industry, which can impact profitability due to fluctuations in industry demand[99] - The company is implementing measures to mitigate risks associated with accounts receivable and talent management to ensure operational efficiency[101][102] Supply Chain Management - The company has developed a strong supply chain management consulting capability, helping clients achieve "just-in-time" production and "zero inventory" management[37] - The company has optimized its supply chain management processes and information systems to enhance efficiency amid challenges from the COVID-19 pandemic and trade tensions[48] - The company has been included in the procurement supplier list of major state-owned enterprises, facilitating rapid growth in municipal infrastructure business[50] - The company reported a gross margin of 9.91% for transaction business in 2020, a slight increase from the previous year despite a significant drop in revenue[58] - The company aims to enhance its supply chain management services in the ICT and medical device sectors, focusing on mobile smart terminals, internet devices, and medical equipment[90] Financial Adjustments and Compliance - The company implemented the new revenue recognition standard starting January 1, 2020, which resulted in a cumulative impact adjustment of -344,811,757.07 CNY to accounts receivable[126] - The company ensured compliance with the new accounting policies as per the approval from the board on April 29, 2020[125] - The financial report did not receive a non-standard audit report, indicating compliance with accounting standards[123] - The company has committed to transparency and fairness in related party transactions, ensuring no harm to minority shareholders[121] Shareholder Information - The total number of shares is 373,318,000, with 29.88% being restricted shares and 70.12% being unrestricted shares[163] - The largest shareholder, Chen Shuzhi, holds 71,599,567 shares, representing 19.18% of the total shares[166] - The company has a total of 27,262 shareholders at the end of the reporting period, an increase from 26,039 at the end of the previous month[165] - The shareholding structure remains stable with no significant changes in the top 10 shareholders[166] - The company has not disclosed any plans for future share issuance or capital restructuring[164] Employee and Management Structure - The total number of employees in the company is 370, with 214 in the parent company and 156 in major subsidiaries[189] - The company has 58 technical personnel and 36 sales personnel among its employees[189] - The total remuneration for directors, supervisors, and senior management during the reporting period is 612.44 million CNY[189] - The company emphasizes talent development and conducts various training programs for its employees[192] - The company has a strict governance structure in compliance with relevant laws and regulations[195] Future Outlook - The company has set a future outlook with a revenue target of 1.8 billion RMB for the next fiscal year, indicating a projected growth of 20%[181] - New product development includes the launch of a supply chain management platform, expected to enhance operational efficiency by 30%[185] - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[182] - A strategic acquisition of a local logistics firm is in progress, which is anticipated to increase the company's logistics capacity by 25%[185] - The company is investing in new technology, with a budget allocation of 100 million RMB for R&D in the upcoming year[184]

Financial Performance - Operating revenue for the period was CNY 1,745,344,542.20, representing a 23.00% increase year-on-year[7] - Net profit attributable to shareholders decreased by 31.33% to CNY 7,463,516.65 compared to the same period last year[7] - The net profit after deducting non-recurring gains and losses fell by 42.99% to CNY 5,838,983.82[7] - Basic earnings per share decreased by 33.33% to CNY 0.02[7] - The company reported a net profit of CNY 710,933,425.13, compared to CNY 676,610,611.21 in the previous period[34] - Net profit for Q3 2020 was CNY 7,455,920.32, down from CNY 10,868,608.17 in the same period last year, representing a decrease of approximately 31.5%[41] - Operating profit for the current period is ¥54,644,141.23, down 34.0% from ¥82,867,095.70 in the previous period[49] - Net profit for the current period is ¥41,075,638.81, a decline of 32.8% compared to ¥61,158,064.87 in the previous period[49] Assets and Liabilities - Total assets increased by 1.53% to CNY 6,612,753,390.94 compared to the end of the previous year[7] - The company's total assets as of September 30, 2020, amounted to ¥6,315,159,852.10, compared to ¥6,207,001,178.30 at the end of 2019[30] - Total liabilities amounted to CNY 5,193,382,686.92, up from CNY 5,131,286,447.38[33] - Current liabilities rose to CNY 5,186,322,341.83 from CNY 5,121,190,066.90[33] - Total liabilities reached CNY 5,131,286,447.38, with current liabilities at CNY 5,121,190,066.90 and non-current liabilities at CNY 10,096,380.48[66] - The company reported a total of CNY 4,401,993,577.35 in current liabilities, reflecting a substantial financial obligation[69] Cash Flow - The net cash flow from operating activities was CNY 186,728,334.78, a significant increase of 170.79%[7] - The net cash flow from operating activities improved by ¥203,861,391.69, resulting in a cash outflow of -¥149,434,107.55 compared to -¥353,295,499.24 in the previous year[17] - The net cash flow from operating activities was -149,434,107.55 CNY, compared to -353,295,499.24 CNY in the previous period, indicating an improvement[57] - Total cash inflow from operating activities reached 44,638,910,541.55 CNY, significantly higher than 24,985,378,681.87 CNY in the previous period[57] - Cash outflow from operating activities was 44,788,344,649.10 CNY, up from 25,338,674,181.11 CNY, leading to a net cash flow deficit[57] Shareholder Information - The total number of shareholders at the end of the reporting period was 27,845[11] - The top shareholder, Chen Shuzhi, holds 19.18% of the shares, totaling 71,599,567 shares[11] Other Income and Expenses - The company reported non-recurring gains of CNY 13,849,734.43, primarily from government subsidies and other income[8] - Other income surged by 429.42% to ¥10,914,517.09, driven by an increase in government subsidies received[17] - Financial expenses showed a significant improvement, with a net income of CNY -22,294,264.98 compared to CNY 26,497,777.16 in the previous year[44] - Financial expenses improved significantly, showing a net income of -¥9,473,767.97 compared to a cost of ¥39,510,511.72 in the previous period[49] Inventory and Receivables - Accounts receivable decreased by 100% to ¥0, as the company's receivable notes were accepted[15] - Prepayments rose by 38.93% to ¥250,254,357.62, attributed to an increase in procurement prepayments[15] - Inventory increased by 63.49% to ¥160,672,761.05, indicating a rise in the company's end-of-period stock[15] Market Strategy - The company plans to expand its market presence and invest in new technologies to enhance operational efficiency[36] Comprehensive Income - The total comprehensive income for Q3 2020 was CNY 12,178,174.04, compared to CNY 7,033,828.79 in the previous year, showing an increase of approximately 73%[42] - The company reported a total comprehensive income of ¥44,138,674.88, down from ¥56,548,283.18 in the previous period[50] Taxation - The company experienced a significant increase in tax expenses, which amounted to CNY 1,160,661.40, compared to CNY 2,737,323.55 in the previous year[41] - The tax expense for the current period is ¥13,110,598.57, a decrease from ¥21,931,303.35, reflecting improved tax efficiency[49] Research and Development - Research and development expenses were CNY 3,857,364.33, slightly down from CNY 4,336,073.48, indicating a decrease of approximately 11%[44] - Research and development expenses for the current period are ¥11,387,589.13, slightly down from ¥12,975,878.73, indicating a focus on maintaining R&D investment[48]